Your institution may have access to this item. Find your institution then sign in to continue.
Title
Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points.
Authors
Bloomfield, D J; Krahn, M D; Neogi, T; Panzarella, T; Smith, T J; Warde, P; Willan, A R; Ernst, S; Moore, M J; Neville, A; Tannock, I F
Publication
Journal of Clinical Oncology, 1998, Vol 16, Issue 6, p2272